Press Releases

ITASCA, Ill., March 5, 2020 /PRNewswire/ -- Since our last statement on Jan. 31, the National Safety Council has continued to follow the data about the coronaviru

BLOOMFIELD, Conn., March 5, 2020 /PRNewswire/ -- Cigna (NYSE: CI) customers will have access to coronavirus (COVID-19) testing, as prescribed by health practitioners, and the company will waive all co-pays or cost-shares to help fight the rapid spread of the virus in the U.S. and for its globally mobile customers.

NEWPORT BEACH, Calif., March 5, 2020 /PRNewswire/ -- Vital Data Technology, LLC (https://vitaldatatech.com/), a data science driven healthcare information technology com

WASHINGTON, March 5, 2020 /PRNewswire/ -- The ATA, the premier organization working to accelerate the adoption of telehealth, today commended Congressional leaders for including a provision to w

NEWARK, N.J., March 5, 2020 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), reported revenue of $1.2 million and a loss per diluted share of $0.08 for the fiscal quarter ended January 31, 2020.

MONMOUTH JUNCTION, N.J., March 5, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO) a critical care immunotherapy leader commercializing its

NEW YORK and BOSTON, March 5, 2020 /PRNewswire/ -- Royalty Pharma announced today that it has acquired Massachusetts General Hospital's (MGH) royalty interest in Entyvio (vedolizumab) for $94 million. Entyvio is a monoclonal antibody that is used in the treatment of ulcerative colitis and Crohn's diseas

MCKINNEY, Texas, March 5, 2020 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) announced that its Board of Directors has raised the quarterly dividend to $.1875 per share on all of the outstanding common stock of the Company held of record as of the close of business of the Company's transfer agent on April 3,

AUSTIN, Texas, March 5, 2020 /PRNewswire/ -- Choose Health, a physician-developed health testing and tracking service, has unveiled their pilot product, the

NASHVILLE, Tenn., March 5, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport"), a global leader in life sciences solutions, today announced financial results for the three and twelve-month periods ended December 31, 2019.